ruxolitinib
novartis,incyte
['#mpn', 'ruxolitinib', 'mpnsm', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)']
#ash22| presents final results from the ruxopeg phase 1/2 trial investigating rux with peg ifna for pts with mf. he highlights 70% of pts reached the primary study endpoint and was maintained at 12 months post treatment #mpn #mpnsm #medicalcongress 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm